Literature DB >> 11557693

Maintaining the integrity of the scientific record.

R Smith.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2001        PMID： 11557693      PMCID： PMC1121173          DOI： 10.1136/bmj.323.7313.588

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Is academic medicine for sale?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Wyeth suppresses research on pill, programme claims.

Authors:  G van Heteren
Journal:  BMJ       Date:  2001-03-10

4.  Effect of flutamide on survival in patients with pancreatic cancer. Results are impressive.

Authors:  S J Wigmore; K C Fearon; O J Garden
Journal:  BMJ       Date:  1999-01-30

5.  Assessing faculty financial relationships with industry: A case study.

Authors:  E A Boyd; L A Bero
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

Review 6.  Influences on the quality of published drug studies.

Authors:  L A Bero; D Rennie
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

7.  Authorship is dying: long live contributorship.

Authors:  R Smith
Journal:  BMJ       Date:  1997-09-20

8.  Thyroid storm.

Authors:  D Rennie
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

9.  Twenty steps towards a "closed society" on health.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987 Dec 19-26

10.  Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double blind, placebo controlled trial.

Authors:  B A Greenway
Journal:  BMJ       Date:  1998-06-27
View more
  11 in total

1.  Maintaining the integrity of the scientific record. Scientific standards observed by medical journals can still be improved.

Authors:  Stephen Senn
Journal:  BMJ       Date:  2002-01-19

2.  Making progress with competing interests.

Authors:  Richard Smith
Journal:  BMJ       Date:  2002-12-14

3.  Getting it right: industry sponsorship and medical research.

Authors:  Patricia Baird
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

4.  How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.

Authors:  Elizabeth Wager
Journal:  BMJ       Date:  2003-05-31

5.  Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets.

Authors:  Lorraine E Ferris; C David Naylor
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

6.  Effects of author contribution disclosures and numeric limitations on authorship trends.

Authors:  Robert J McDonald; Kevin L Neff; Melissa L Rethlefsen; David F Kallmes
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

7.  Trial protocols at the BMJ.

Authors:  Giselle Jones; Kamran Abbasi
Journal:  BMJ       Date:  2004-12-11

8.  Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?

Authors:  E J Wagena; P Knipschild
Journal:  J Med Ethics       Date:  2005-05       Impact factor: 2.903

Review 9.  Conflicts of interest in drug development: the practices of Merck & Co., Inc.

Authors:  Laurence J Hirsch
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

10.  Concerned Journals, Editors And ICMJE.

Authors: 
Journal:  Mens Sana Monogr       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.